Apolipoproteins E < Apomorphine < Apoptosis

Facettes :

List of bibliographic references indexed by Apomorphine

Number of relevant bibliographic references: 75.
[20-40] [0 - 20][0 - 50][40-60]

Ident.	Authors (with country if any)	Title
003968 (2005)	Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Hughes [Australie] ; Andrew Evans [Royaume-Uni] ; Alice J. Manson [Royaume-Uni] ; Marion Hoffman [Australie] ; Lesley Swinn [Royaume-Uni] ; Hilary Watt [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]	Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single‐dose challenges
003B04 (2004)	Lorenzo Priano [Italie] ; Gianni Albani [Italie] ; Andrea Brioschi [Italie] ; Sara Calderoni [Italie] ; Leonardo Lopiano [Italie] ; Mario Rizzone [Italie] ; Roberta Cavalli [Italie] ; Maria Rosa Gasco [Italie] ; Francesco Scaglione [Italie] ; Franco Fraschini [Italie] ; Bruno Bergamasco [Italie] ; Alessandro Mauro [Italie]	Transdermal apomorphine permeation from microemulsions: A new treatment in Parkinson's disease
003B37 (2004)	Jan C. M. Zijlmans [Royaume-Uni, Pays-Bas] ; Berengere Debilly [France] ; Olivier Rascol [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Franck Durif [France]	Safety of entacapone and apomorphine coadministration in levodopa‐treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double‐blind, placebo‐controlled, cross‐over study
003C68 (2004)	Svenja Happe [Allemagne] ; Tobias Tings [Allemagne] ; Kathrin Helmschmied [Allemagne] ; Karin Neubert [Allemagne] ; Wolfgang Wuttke [Allemagne] ; Walter Paulus [Allemagne] ; Claudia Trenkwalder [Allemagne]	Levodopa treatment does not affect low‐dose apomorphine test in patients with Parkinson's disease
003D65 (2004)	Montse Alegret [Espagne] ; Francesc Valldeoriola [Espagne] ; Majosé Martí [Espagne] ; Manuela Pilleri [Espagne] ; Carme Junqué [Espagne] ; Jordi Rumià [Espagne] ; Eduardo Tolosa [Espagne]	Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease
004226 (2002)	Petr Kanovsk [République tchèque] ; Dagmar Kubová ; Martin Bares ; Hana Hortová ; Hana Streitová ; Ivan Rektor ; Vladimír Znojil	Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: results of a two-year, prospective follow-up.
004360 (2002)	Giulio Cicarelli [Italie] ; Maria Teresa Pellecchia [Italie] ; Giuseppe De Michele [Italie] ; Gilberto Pizzolato [Italie] ; Paolo Barone [Italie]	Paradoxical response to apomorphine in a case of atypical parkinsonism
004481 (2002)	Guillermo Paradiso [Canada] ; Farooq Khan [Canada] ; Robert Chen [Canada]	Effects of apomorphine on flexor reflex and periodic limb movement
004520 (2002)		DA agonists ‐ Non‐Ergot derivaties: Apomorphine
004571 (2002)	Alice J. Manson [Royaume-Uni] ; Kirsten Turner [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]	Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long‐term follow‐up study of 64 patients
004661 (2001)	Han-Cheng Wang [Taïwan] ; Yoloung Hsieh [Taïwan]	Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy
004745 (2001)	Susan H. Fox [Royaume-Uni] ; Brian Henry [Royaume-Uni] ; Micheal P. Hill [Royaume-Uni] ; David Peggs [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni]	Neural mechanisms underlying peak‐dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha2 adrenoceptor antagonist idazoxan
004836 (2001)	Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie]	Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease
004958 (2000)	Stewart A. Factor [États-Unis] ; Diane L. Brown [États-Unis] ; Eric S. Molho [États-Unis]	Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease
004A78 (2000)	Sarah A. Treseder [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni]	Endogenous dopaminergic tone and dopamine agonist action
004B41 (2000)	Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]	Apomorphine: An underutilized therapy for Parkinson's disease
004C06 (1999)	Franck Durif [France] ; Marie Vidailhet [France] ; Bérangère Debilly [France] ; Yves Agid [France]	Worsening of levodopa‐induced dyskinesias by motor and mental tasks
004C58 (1999)	Anette Schrag [Royaume-Uni] ; Ludwig Schelosky [Allemagne] ; Udo Scholz [Allemagne] ; Werner Poewe [Autriche]	Reduction of parkinsonian signs in patients with Parkinson's disease by dopaminergic versus anticholinergic single‐dose challenges
004D29 (1999)	Fabrizio Stocchi ; Carlo Farina [Italie] ; Gianpietro Nordera [Italie] ; Stefano Ruggieri	Implantable venous access system for apomorphine infusion in complicated Parkinson's disease
004D38 (1999)	Marcelo Merello [Argentine] ; Andrew Lees (neurologue) [Royaume-Uni] ; Jorge Balej [Argentine] ; Angel Cammarota [Argentine] ; Ram N Leiguarda [Argentine]	GPi Firing rate modification during beginning‐of‐dose motor deterioration following acute administration of apomorphine
004E08 (1999)	Edna Grünblatt [Israël] ; Silvia Mandel [Israël] ; Tamara Berkuzki [Israël] ; M. B. H. Youdim [Israël]	Apomorphine protects against MPTP‐induced neurotoxicity in mice

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Apomorphine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Apomorphine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Apomorphine
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024